Luvira
- Product NDC
- 69336-351
- 11-digit product format
- 693360351
- Labeler code
- 69336
- Product ID
- 69336-351_99d7525d-b62e-7f8e-e053-2a95a90a2080
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Luvira
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Sterling-Knight Pharmaceuticals, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2019-11-07
- Marketing end
- 0000-00-00
- Substance
- OMEGA-3-ACID ETHYL ESTERS; 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)-; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)-
- Active strength
- 1220 mg/1; mg/1; mg/1
- Pharmacologic classes
- Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record